Join the club for FREE to access the whole archive and other member benefits.

Competitors in big pharma accused of conspiring to inflate generic drug prices

Inflated prices of more than 100 generic drugs by as much as 1000 per cent

12-May-2019

Key points from article :

44 US states filed a lawsuit against leading pharma for unlawful inflation of generic drug prices.

Increased prices of more than 100 generic drugs that treat various diseases.

Competitors agreed to cooperate on pricing and raised prices by as much as 1000 per cent on many drugs as possible.

Most of the collusive activity occurred from July 2013 to January 2015.

Mentioned in this article:

Click on resource name for more details.

Novartis

Global medicines company for developing and producing drugs.

Pfizer

Company developing, producing and marketing affordable, high quality generic drugs and specialty pharmaceuticals

Teva Pharmaceuticals Industries

Company developing, producing and marketing affordable, high quality generic drugs and specialty pharmaceuticals

Topics mentioned on this page:
Big Pharma